New metallophamaceutic reduced renal injury induced by non-steroidal anti-inflammatory
Acta cir. bras; 34 (12), 2019
Publication year: 2019
Abstract Purpose To evaluate the effect of Rut-bpy (Cis-[Ru(bpy)2(SO3)(NO)]PF 6), a novel nitric oxide donor, able to modulate the histological changes caused by the NASID (meloxicam). Methods Wistar rats were assigned into three groups (n=6 rats/group): Sham group (saline solution), NSAID group (meloxicam - 15 mg/kg) and Rut-bpy group (100 mg/kg of Rut-bpy associated with 15mg/kg of meloxicam). At the end of experiments, kidneys were removed for histological study, fractal dimension and lacunarity in all animals. Results At the histological examination, all animals (six animals - 100 %) in the NSAID group had membrane thickening and other changes (necrosis, acute tubular congestion and vascular congestion); on the other hand, only one animal (16.6 %) of the Rut-bpy group had congestion. The fractal dimension and lacunarity were greater in the control and Rut-bpy group than in NSAIDs group (p<0.05). Conclusion Rut-bpy may prevent renal histological changes in rats caused by meloxicam.
Antiinflamatorios no Esteroideos/efectos adversos, Fractales, Enfermedades Renales/inducido químicamente, Enfermedades Renales/patología, Enfermedades Renales/prevención & control, Meloxicam/efectos adversos, Donantes de Óxido Nítrico/farmacología, Compuestos Organometálicos/farmacología, Distribución Aleatoria, Ratas Wistar, Reproducibilidad de los Resultados, Rutenio/farmacología